Abstract
On the basis of antimicrobial activity, resistance development, pharmacokinetics, side effects and pre-clinical results, the applicability of the quinolones ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin is assessed. These quinolones seem especially useful in infections in hospitalized patients, in gonococcal infections and in urinary tract infections. Also salmonellosis and shigellosis might be indications for quinolones.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Smith JI. Awakening the slumbering potential of the 4-quinolone antibacterials. Pharm J 1984:229–305.
Shah PM, ed. Reports on gyrase inhibitions. Quinolones Bull, October 1984, April, June and November 1985.
Chapman SI, Speller DC, Reeves DS. Resistance to ciprofloxacin. Lancet 1985;12:39.
Humphreys H, Mulvihill E. Ciprofloxacin-resistantStaphylococcus aureus. Lancet 1985;2:383.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Klingeren, B. Place of quinolones in the therapeutic armoury. Pharmaceutisch Weekblad Scientific Edition 8, 40–41 (1986). https://doi.org/10.1007/BF01975478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01975478